Mirae Asset Global Investments
GNOM icon

Mirae Asset Global Investments’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Mirae Asset Global Investments’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-94,437
Closed -$4.43M – 1942
2024
Q1 		$4.43M Buy
94,437
+13,294
+16% +$606K 0.01% 924
2023
Q4 		$3.75M Sell
81,143
-12,690
-14% -$517K 0.01% 991
2023
Q3 		$3.82M Buy
93,833
+8,098
+9% +$369K 0.01% 940
2023
Q2 		$4.16M Sell
85,735
-8,702
-9% -$435K 0.01% 943
2023
Q1 		$4.65M Sell
94,437
-31,965
-25% -$1.64M 0.01% 880
2022
Q4 		$6.4M Sell
126,402
-6,396
-5% -$330K 0.02% 746
2022
Q3 		$6.67M Sell
132,798
-15,210
-10% -$858K 0.02% 712
2022
Q2 		$7.24M Sell
148,008
-11,373
-7% -$577K 0.02% 716
2022
Q1 		$9.58M Sell
159,381
-279,915
-64% -$17.7M 0.02% 678
2021
Q4 		$34.9M Sell
439,296
-34,583
-7% -$2.91M 0.07% 304
2021
Q3 		$42.1M Buy
473,879
+227,850
+93% +$21.3M 0.11% 235
2021
Q2 		$24.5M Sell
246,029
-29,878
-11% -$2.65M 0.07% 351
2021
Q1 		$24.8M Buy
275,907
+200,737
+267% +$19.8M 0.09% 298
2020
Q4 		$7.13M Buy
75,170
+25,087
+50% +$2.1M 0.03% 581
2020
Q3 		$3.6M Buy
+50,083
New +$3.59M 0.02% 619

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Mirae Asset Global Investments's GNOM Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2024, closing a stake of 94,437 shares — an estimated $4.43M sold.

Mirae Asset Global Investments first reported a position in GNOM in Q3 2020 and held it in 15 quarters. The position peaked at $42.1M in Q3 2021. 64 funds tracked by Wall St. Rank hold GNOM as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 94,437 Global X Genomics & Biotechnology ETF shares in Q2 2024, an estimated $4.43M.
  • Mirae Asset Global Investments first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and held it in 15 quarters.
  • Mirae Asset Global Investments's Global X Genomics & Biotechnology ETF position peaked at $42.1M in Q3 2021.
  • 64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.